News Lavipharm S.A.

Equities

Delayed Athens S.E. Other stock markets 07:10:46 2024-05-16 EDT			5-day change	1st Jan Change
0.979 ^EUR	+2.41%		+13.72%	+21.86%

02-28	Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi.	CI

Lavipharm S A : Annual Analysts Briefing	04-24	PU
Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	02-28	CI
Lavipharm S A : ANNOUNCEMENT	12-11	PU
Lavipharm S A : enters into a new asset purchase agreement	12-11	PU
Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi.	12-10	CI
Lavipharm S A : Asset Purchase Agreement for Lavipharm	12-01	PU
Lavipharm S.A. signing of an asset purchase agreement to acquire Lonarid N and Lonalgal from Boehringer Ingelheim International GmbH.	11-30	CI
Lavipharm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	11-08	CI
Lavipharm S A : FINANCIAL RESULTS FIRST HALF OF 2023	23-09-21	PU
Lavipharm S A : First Half 2023 Financial Results – Strong EBITDA increase	23-09-21	PU
Lavipharm S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-21	CI
Lavipharm S A : Annual Shareholders’ Meeting	23-07-06	PU
Lavipharm S A : PRESS RELEASE SHAREHOLDERS MEETING	23-07-06	PU
Lavipharm S.A.(ATSE:LAVI) added to ATHEX Composite Index	23-06-21	CI
Lavipharm S A : Press Release Extraordinary Shareholders’ Meeting	23-05-26	PU
Lavipharm S A : Results Q1 2023	23-05-04	PU
Lavipharm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04	CI
Lavipharm S A : AMENDMENT OF THE 2023 FINANCIAL CALENDAR	23-04-27	PU
Lavipharm S A : ANNOUNCEMENT	23-03-28	PU
Lavipharm S A : Announcement 1668/2023	23-03-15	PU

No results for this search